GSK3B and Alzheimer disease: Regarding the above-mentioned implication of GSK-3β in AD, as well as the controversial role of fractalkine signaling in the disease, and taking into account our in vitro and in vivo results, we finally studied fractalkine levels in brain extracts from patients of different Braak stages (see Fig. S7).